Baqar’s Premier League 2025 Ignites Mumbai with a High-Voltage Cardio Night
Over 180+ global participants unite for an electrifying celebration of fitness, resilience,…
MICHELIN Guide Returns to Vegas with Launch of New Southwest Edition
LAS VEGAS - Announced today, in partnership with Arizona, Nevada, New Mexico,…
Menarini Group Presents Elacestrant (ORSERDU) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium
In addition, the expansive elacestrant clinical development program updates reinforce its potential as…
Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others
TOKYO, Dec. 8, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced…
ADFW Opens with Spotlight on Abu Dhabi’s Global Ambition and Major Humanitarian Pledge
ABU DHABI, UAE, Dec. 8, 2025 /PRNewswire/ -- Abu Dhabi Finance Week…
With Child Deaths Projected to Rise for the First Time in a Century, Gates Foundation and Mohamed Bin Zayed Foundation for Humanity Urge Action as World Faces Critical Turning Point
At Goalkeepers Abu Dhabi, global leaders outline a path to improve and…
Altair HyperWorks 2026 Delivers Design and Simulation at Scale with AI
Latest release enables faster, more confident design decisions at scale with accelerated…
Eastman Auto & Power Accelerates Its Global Energy Portfolio with New Telecom Battery & Hybrid Inverter Range
Showcases next-generation power solutions at infraXchange Singapore 2025NEW DELHI, Dec. 8, 2025…
Allison Worldwide Expands Global Leadership with New Europe CEO
Former Hotwire UK CEO and Edelman MD Jeremy Lucas to turbocharge Allison's…
Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting and Exposition
93% overall response and 76% complete response rates with median progression-free survival…
